Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays an updated software revision tag, changing from v3.6.0 to v3.6.2. This reflects a platform update rather than a change to the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-06-27T01:03:39.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now explicitly indicates that recruitment is closed and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study). A formatting update replaces the Interventions heading from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the revision tag from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T13:38:16.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, indicating the latest documentation update has been applied.
    Difference
    0.0%
    Check dated 2026-06-05T09:52:11.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The site update indicates a new software revision from v3.5.3 to v3.5.4, signaling an incremental platform upgrade. This change relates to the site’s underlying version and does not modify the visible content or features on the page.
    Difference
    0.0%
    Check dated 2026-05-15T03:22:08.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The site revision has been updated from v3.5.2 to v3.5.3, indicating a new software release. This backend update does not alter the visible study details content on the page.
    Difference
    0.0%
    Check dated 2026-04-30T17:36:14.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Updated the displayed region name for the Bordeaux site from “Nouvelle-Aquitaine” to “New Aquitaine,” while retaining the same city and postal code.
    Difference
    0.0%
    Check dated 2026-04-23T14:25:36.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.